Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilretta for Synovial Inflammation in Knee OA
NCT03529942Phase 3Completed
- Sponsor
- Pacira BioSciences
- Start
- Apr 2018
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of triamcinolone acetonide in osteoarthritis (OA), sponsored by Pacira BioSciences. Started Apr 2018; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03529942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529942.